Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...
A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
Hosted on MSN1d
Tenecteplase No Longer Off-Label as Stroke LyticNotably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...
Research predicts stroke deaths may rise 50% globally by 2050, with younger people increasingly affected. Learn effective ...
The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the standard 60-minute infusion of alteplase.
Smoking more than doubles the risk of unexplained strokes among younger adults, a new study warns. And heavy smoking is even ...
Hosted on MSN1d
This quick daily habit may reduce the risk of stroke and other heart conditions, a new study revealsBut while doing enough cardio and eating well is very important, new research suggests there could be an even simpler way to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback